KROS
Keros Therapeutics, Inc. Common Stock
$10.61
-3.81%
-0.42
Notify me if price changes either direction
Buy KROS stocks now with Interactive Brokers – the most advanced investment platform
Contents
- Performance
- Key stats
- Financials
- US politician trades
Loading
Key Stats
Market cap.
210.0M
Enterprise value
-55194608
Trailing PE
4.610565
Forward PE
-1.8969022
PEG Ratio
-0.034650242094456
Enterprise to EBITDA
0.522
Enterprise to revenue
-1.663
Price to book MRQ
0.7329879
Price to sales TTM
6.3284726
Financials
Fiscal Year Ends
2025-12-31
Most Recent Quarter (MRQ)
2026-03-31
Revenue (TTM)
33.2M
EBITDA
44.2M
Diluted EPS TTM
-2.53
Total Cash (MRQ)
281.5M
Current ratio (MRQ)
22.615
Operating Cash Flow (TTM)
-57195000
KROS trades by the US politicians
Percentage
0%
0 sells
100%
0 buys
Amount
$0
0 sells
$0
0 buys
In the last 0 months
July 2026
| Senator | Action | Amount | Date | Owner | Type |
|---|---|---|---|---|---|
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
| Senator | Type | 100 - 200 | Jan 2024 | Finbold | Senate |
There are no signals yet
Keep up to date with our realtime buy and sell alerts, exclusive insights, and in-depth analysis.
